Kris, Mark G.

Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors

Yu, H. A., Sima, C. S., Drilon, A. E. D. C., Varghese, A. M., Pietanza, M. C., Azzoli, C. G., Rizvi, N. A., Krug, L. M., Kris, M. G., Miller, V. A., et al. (2012) · Journal of Clinical Oncology

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 10